Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial

BACKGROUND: Radiotherapy, preferably combined with chemotherapy, is the treatment standard for locally advanced, unresectable non-small cell lung cancer (NSCLC). The tumor response to different therapy protocols is variable, with hypoxia known to be a major factor that negatively influences treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Askoxylakis, Vasileios (VerfasserIn) , Dinkel, Julien (VerfasserIn) , Eichinger, Monika (VerfasserIn) , Strauss, Ludwig G. (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) , Kopp-Schneider, Annette (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Huber, Peter E. (VerfasserIn) , Bischof, Marc (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Thieke, Christian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 September 2012
In: Radiation oncology
Year: 2012, Jahrgang: 7
ISSN:1748-717X
DOI:10.1186/1748-717X-7-157
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1748-717X-7-157
Volltext
Verfasserangaben:Vasileios Askoxylakis, Julien Dinkel, Monika Eichinger, Bram Stieltjes, Gregor Sommer, Ludwig G. Strauss, Antonia Dimitrakopoulou-Strauss, Annette Kopp-Schneider, Uwe Haberkorn, Peter E. Huber, Marc Bischof, Jürgen Debus and Christian Thieke

MARC

LEADER 00000caa a2200000 c 4500
001 1580060994
003 DE-627
005 20220814220508.0
007 cr uuu---uuuuu
008 180815s2012 xx |||||o 00| ||eng c
024 7 |a 10.1186/1748-717X-7-157  |2 doi 
035 |a (DE-627)1580060994 
035 |a (DE-576)510060994 
035 |a (DE-599)BSZ510060994 
035 |a (OCoLC)1341016791 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Askoxylakis, Vasileios  |d 1978-  |e VerfasserIn  |0 (DE-588)133302261  |0 (DE-627)69132753X  |0 (DE-576)276112148  |4 aut 
245 1 0 |a Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer  |b the HIL trial  |c Vasileios Askoxylakis, Julien Dinkel, Monika Eichinger, Bram Stieltjes, Gregor Sommer, Ludwig G. Strauss, Antonia Dimitrakopoulou-Strauss, Annette Kopp-Schneider, Uwe Haberkorn, Peter E. Huber, Marc Bischof, Jürgen Debus and Christian Thieke 
264 1 |c 14 September 2012 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.08.2018 
520 |a BACKGROUND: Radiotherapy, preferably combined with chemotherapy, is the treatment standard for locally advanced, unresectable non-small cell lung cancer (NSCLC). The tumor response to different therapy protocols is variable, with hypoxia known to be a major factor that negatively influences treatment effectiveness. Visualisation of tumor hypoxia prior to the use of modern radiation therapy strategies, such as intensity modulated radiation therapy (IMRT), might allow optimized dose applications to the target volume, leading to improvement of therapy outcome. (18)F-fluoromisonidazole dynamic positron emission tomography and computed tomography ((18) F-FMISO dPET-CT) and functional magnetic resonance imaging (functional MRI) are attractive options for imaging tumor hypoxia. METHODS/DESIGN: The HIL trial is a single centre study combining multimodal hypoxia imaging with (18) F-FMISO dPET-CT and functional MRI, with intensity modulated radiation therapy (IMRT) in patients with inoperable stage III NSCLC. 15 patients will be recruited in the study. All patients undergo initial FDG PET-CT and serial (18) F-FMISO dPET-CT and functional MRI before treatment, at week 5 of radiotherapy and 6 weeks post treatment. Radiation therapy is performed as inversely planned IMRT based on 4D-CT. DISCUSSION: Primary objectives of the trial are to characterize the correlation of (18) F-FMISO dPET-CT and functional MRI for tumor hypoxia imaging in NSCLC and evaluate possible effects of radiation therapy on tumor re-oxygenation. Further objectives include the generation of data regarding the prognostic value of (18) F-FMISO dPET-CT and functional MRI for locoregional control, progression free survival and overall survival of NSCLC treated with IMRT, which will form the basis for larger clinical trials focusing on possible interactions between tumor oxygenation and radiotherapy outcome. TRIAL REGISTRATION: The ClinicalTrials.gov protocol ID is NCT01617980. 
650 4 |a Algorithms 
650 4 |a Carcinoma, Non-Small-Cell Lung 
650 4 |a Humans 
650 4 |a Hypoxia 
650 4 |a Lung Neoplasms 
650 4 |a Magnetic Resonance Imaging 
650 4 |a Misonidazole 
650 4 |a Multimodal Imaging 
650 4 |a Neoplasm Staging 
650 4 |a Positron-Emission Tomography 
650 4 |a Radiation-Sensitizing Agents 
650 4 |a Radiotherapy Planning, Computer-Assisted 
650 4 |a Radiotherapy, Intensity-Modulated 
650 4 |a Salvage Therapy 
650 4 |a Tomography, X-Ray Computed 
650 4 |a Treatment Outcome 
700 1 |a Dinkel, Julien  |d 1978-  |e VerfasserIn  |0 (DE-588)140755632  |0 (DE-627)621592773  |0 (DE-576)320647374  |4 aut 
700 1 |a Eichinger, Monika  |d 1964-  |e VerfasserIn  |0 (DE-588)1049617525  |0 (DE-627)78269117X  |0 (DE-576)172609712  |4 aut 
700 1 |a Strauss, Ludwig G.  |d 1949-2013  |e VerfasserIn  |0 (DE-588)1108137024  |0 (DE-627)863758835  |0 (DE-576)376098201  |4 aut 
700 1 |a Dimitrakopoulou-Strauss, Antonia  |d 1963-  |e VerfasserIn  |0 (DE-588)1076688373  |0 (DE-627)835256901  |0 (DE-576)167486055  |4 aut 
700 1 |a Kopp-Schneider, Annette  |e VerfasserIn  |0 (DE-588)1119160545  |0 (DE-627)872460444  |0 (DE-576)178153206  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Huber, Peter E.  |d 1965-  |e VerfasserIn  |0 (DE-588)1074678869  |0 (DE-627)832350109  |0 (DE-576)442767803  |4 aut 
700 1 |a Bischof, Marc  |d 1966-  |e VerfasserIn  |0 (DE-588)103275785X  |0 (DE-627)739273825  |0 (DE-576)176908978  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Thieke, Christian  |d 1970-  |e VerfasserIn  |0 (DE-588)129347396  |0 (DE-627)394260066  |0 (DE-576)297612417  |4 aut 
773 0 8 |i Enthalten in  |t Radiation oncology  |d London : BioMed Central, 2006  |g 7(2012) Artikel-Nummer 157, 7 Seiten  |h Online-Ressource  |w (DE-627)508725739  |w (DE-600)2224965-5  |w (DE-576)260614815  |x 1748-717X  |7 nnas  |a Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer the HIL trial 
773 1 8 |g volume:7  |g year:2012  |g extent:7  |a Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer the HIL trial 
856 4 0 |u http://dx.doi.org/10.1186/1748-717X-7-157  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180815 
993 |a Article 
994 |a 2012 
998 |g 129347396  |a Thieke, Christian  |m 129347396:Thieke, Christian  |d 910000  |d 911400  |e 910000PT129347396  |e 911400PT129347396  |k 0/910000/  |k 1/910000/911400/  |p 13  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 12 
998 |g 103275785X  |a Bischof, Marc  |m 103275785X:Bischof, Marc  |d 910000  |d 911400  |e 910000PB103275785X  |e 911400PB103275785X  |k 0/910000/  |k 1/910000/911400/  |p 11 
998 |g 1074678869  |a Huber, Peter E.  |m 1074678869:Huber, Peter E.  |d 50000  |e 50000PH1074678869  |k 0/50000/  |p 10 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1119160545  |a Kopp-Schneider, Annette  |m 1119160545:Kopp-Schneider, Annette  |d 50000  |e 50000PK1119160545  |k 0/50000/  |p 8 
998 |g 1076688373  |a Dimitrakopoulou-Strauss, Antonia  |m 1076688373:Dimitrakopoulou-Strauss, Antonia  |d 910000  |d 911400  |e 910000PD1076688373  |e 911400PD1076688373  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 1108137024  |a Strauss, Ludwig G.  |m 1108137024:Strauss, Ludwig G.  |d 50000  |e 50000PS1108137024  |k 0/50000/  |p 6 
998 |g 1049617525  |a Eichinger, Monika  |m 1049617525:Eichinger, Monika  |d 50000  |e 50000PE1049617525  |k 0/50000/  |p 3 
998 |g 140755632  |a Dinkel, Julien  |m 140755632:Dinkel, Julien  |d 910000  |d 911400  |e 910000PD140755632  |e 911400PD140755632  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 133302261  |a Askoxylakis, Vasileios  |m 133302261:Askoxylakis, Vasileios  |d 910000  |d 911400  |e 910000PA133302261  |e 911400PA133302261  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1580060994  |e 3022388349 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Vasileios","family":"Askoxylakis","display":"Askoxylakis, Vasileios","role":"aut"},{"given":"Julien","family":"Dinkel","display":"Dinkel, Julien","role":"aut"},{"display":"Eichinger, Monika","role":"aut","given":"Monika","family":"Eichinger"},{"role":"aut","display":"Strauss, Ludwig G.","given":"Ludwig G.","family":"Strauss"},{"role":"aut","display":"Dimitrakopoulou-Strauss, Antonia","family":"Dimitrakopoulou-Strauss","given":"Antonia"},{"family":"Kopp-Schneider","given":"Annette","display":"Kopp-Schneider, Annette","role":"aut"},{"role":"aut","display":"Haberkorn, Uwe","family":"Haberkorn","given":"Uwe"},{"display":"Huber, Peter E.","role":"aut","given":"Peter E.","family":"Huber"},{"role":"aut","display":"Bischof, Marc","family":"Bischof","given":"Marc"},{"display":"Debus, Jürgen","role":"aut","family":"Debus","given":"Jürgen"},{"display":"Thieke, Christian","role":"aut","given":"Christian","family":"Thieke"}],"language":["eng"],"id":{"doi":["10.1186/1748-717X-7-157"],"eki":["1580060994"]},"note":["Gesehen am 15.08.2018"],"relHost":[{"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer the HIL trialRadiation oncology","part":{"text":"7(2012) Artikel-Nummer 157, 7 Seiten","year":"2012","volume":"7","extent":"7"},"note":["Gesehen am 06.09.10"],"id":{"eki":["508725739"],"zdb":["2224965-5"],"issn":["1748-717X"]},"pubHistory":["1.2006 -"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2006","publisher":"BioMed Central","dateIssuedDisp":"2006-","publisherPlace":"London"}],"recId":"508725739","title":[{"title":"Radiation oncology","title_sort":"Radiation oncology"}]}],"name":{"displayForm":["Vasileios Askoxylakis, Julien Dinkel, Monika Eichinger, Bram Stieltjes, Gregor Sommer, Ludwig G. Strauss, Antonia Dimitrakopoulou-Strauss, Annette Kopp-Schneider, Uwe Haberkorn, Peter E. Huber, Marc Bischof, Jürgen Debus and Christian Thieke"]},"origin":[{"dateIssuedDisp":"14 September 2012","dateIssuedKey":"2012"}],"physDesc":[{"extent":"7 S."}],"title":[{"title":"Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer","title_sort":"Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer","subtitle":"the HIL trial"}],"recId":"1580060994"} 
SRT |a ASKOXYLAKIMULTIMODAL1420